1. Home
  2. ECOR vs CUBA Comparison

ECOR vs CUBA Comparison

Compare ECOR & CUBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • CUBA
  • Stock Information
  • Founded
  • ECOR 2005
  • CUBA 1992
  • Country
  • ECOR United States
  • CUBA United States
  • Employees
  • ECOR N/A
  • CUBA N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CUBA Investment Managers
  • Sector
  • ECOR Health Care
  • CUBA Finance
  • Exchange
  • ECOR Nasdaq
  • CUBA Nasdaq
  • Market Cap
  • ECOR 39.3M
  • CUBA 38.4M
  • IPO Year
  • ECOR 2018
  • CUBA N/A
  • Fundamental
  • Price
  • ECOR $7.89
  • CUBA $2.38
  • Analyst Decision
  • ECOR Strong Buy
  • CUBA
  • Analyst Count
  • ECOR 1
  • CUBA 0
  • Target Price
  • ECOR $15.00
  • CUBA N/A
  • AVG Volume (30 Days)
  • ECOR 36.3K
  • CUBA 93.9K
  • Earning Date
  • ECOR 11-06-2024
  • CUBA 01-01-0001
  • Dividend Yield
  • ECOR N/A
  • CUBA 20.83%
  • EPS Growth
  • ECOR N/A
  • CUBA N/A
  • EPS
  • ECOR N/A
  • CUBA N/A
  • Revenue
  • ECOR $21,281,000.00
  • CUBA N/A
  • Revenue This Year
  • ECOR $60.05
  • CUBA N/A
  • Revenue Next Year
  • ECOR $41.34
  • CUBA N/A
  • P/E Ratio
  • ECOR N/A
  • CUBA N/A
  • Revenue Growth
  • ECOR 95.83
  • CUBA N/A
  • 52 Week Low
  • ECOR $5.02
  • CUBA $2.25
  • 52 Week High
  • ECOR $8.19
  • CUBA $4.14
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 67.25
  • CUBA 65.42
  • Support Level
  • ECOR $7.07
  • CUBA $2.28
  • Resistance Level
  • ECOR $8.19
  • CUBA $2.34
  • Average True Range (ATR)
  • ECOR 0.49
  • CUBA 0.03
  • MACD
  • ECOR 0.03
  • CUBA 0.01
  • Stochastic Oscillator
  • ECOR 79.02
  • CUBA 91.67

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About CUBA Herzfeld Caribbean Basin Fund Inc. (The)

Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.

Share on Social Networks: